Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
04/2012
04/24/2012US8163710 Reduction of graft-versus-host disease by modulation of SHIP activity
04/24/2012US8163709 TAK1-D mediated induction of cell death in human cancer cells by specific sequence short double-stranded RNAS
04/24/2012US8163708 Pharmaceutical composition comprising anti-mirna antisense oligonucleotide
04/24/2012US8163691 Compositions and methods for identifying agents which modulate PTEN function and PI-3 kinase pathways
04/24/2012US8163558 Plasmids for transforming bacteria of the acidithiobacillus spp. genus, and transformation method
04/24/2012US8163557 Chimaeric human papillomavirus 16 L1 virus-like particles and a method for preparing the particles
04/24/2012US8163552 Immunoglobulin specific to tumor cells for use in diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents
04/24/2012US8163550 Enhancement of immune responses by 4-1BB-binding agents
04/24/2012US8163548 Recombinant bicistronic flaviviruses and methods of use thereof
04/24/2012US8163547 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
04/24/2012US8163546 Mammalian cell-based immunoglobulin display libraries
04/24/2012US8163545 Vaccine against pandemic strains of influenza viruses
04/24/2012US8163544 Methods and compositions for increasing tissue tropism of recombinant adenoviral vectors
04/24/2012US8163543 AAV vectors produced in insect cells
04/24/2012US8163542 Potent combinations of mRNA transport elements
04/24/2012US8163532 Microorganisms with a reactivation system for cob(I)alamin-dependent methionine synthase
04/24/2012US8163529 Nicking endonuclease methods and compositions
04/24/2012US8163528 Nucleic acid molecules encoding thymidine kinase fusion proteins
04/24/2012US8163522 Human TNF receptor
04/24/2012US8163520 Nucleic acids encoding a chimeric polypeptide comprising IL-7 and HGF-beta chain and methods of use
04/24/2012US8163508 Methods for predicting pregnancy outcome in a subject by hCG assay
04/24/2012US8163506 Use of toll-like receptor-expressing cells
04/24/2012US8163494 Method for assessing metastatic properties of breast cancer
04/24/2012US8163305 Targeted cross-linked nanoparticles and their use in vivo gene delivery
04/24/2012US8163280 Antibodies to c-Met
04/24/2012CA2817758A1 Drought tolerant plants
04/24/2012CA2627593C Dopaminergic neuron proliferative progenitor cell marker nato3
04/24/2012CA2612690C Methylation specific detection
04/24/2012CA2583722C Nematode resistant transgenic plants
04/24/2012CA2549037C Expression vector and use thereof
04/24/2012CA2539256C Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells
04/24/2012CA2532460C Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof
04/24/2012CA2452447C Antagonistic anti-htnfsf13b human antibodies
04/24/2012CA2350226C Protein expression vector and utilization thereof
04/24/2012CA2339529C Isolated and purified human soluble guanylyl cyclase .alpha.1/.beta.1 (hsgc .alpha.1/.beta.1)
04/24/2012CA2313245C Strain of bacteria of the species lactobacillus paracasei subsp. paracasei, composition thereof for use in food and product containing said strain
04/24/2012CA2268812C Method for producing transgenic animal models with modulated phenotype and animals produced therefrom
04/24/2012CA2239072C Recombinant live vaccine containing feline herpes virus type 1, particularly for treating feline infectious peritonitis
04/19/2012WO2012051599A2 Modulation neural pathways
04/19/2012WO2012051504A2 Quantitative multiplexed identification of nucleic acid targets
04/19/2012WO2012051491A1 Compositions and methods for controlling neurotropic viral pathogenesis by micro-rna targeting
04/19/2012WO2012051431A2 Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders
04/19/2012WO2012051327A2 Method of dual-adapter recombination for efficient concatenation of multiple dna fragments in shuffled or specified arrangements
04/19/2012WO2012051207A2 FRAGMENT OF SECRETED HEAT SHOCK PROTEIN-90ALPHA (Hsup90ALPHA) AS VACCINES OR EPITOPE FOR MONOCLONAL ANTIBODY DRUGS OR TARGET FOR SMALL MOLECULE DRUGS AGAINST A RANGE OF SOLID HUMAN TUMORS
04/19/2012WO2012051152A2 Novel dna templates for small rna production in mammalian cells
04/19/2012WO2012051111A2 Human oncostatin m antibodies and methods of use
04/19/2012WO2012050975A2 Novel circular mammalian rna molecules and uses thereof
04/19/2012WO2012050919A2 Chimeric spider silk and uses thereof
04/19/2012WO2012050893A2 Immunogenic polypeptides having an immunogenic scaffold protein and a loop peptide, presenting a 3074- or 2219/2557- monoclonal antibody-targeted epitope, which is present in the hiv gp120 protein
04/19/2012WO2012050884A2 Cardiac glycosides are potent inhibitors of interferon-beta gene expression
04/19/2012WO2012050787A1 Fungal nucleic acid extraction
04/19/2012WO2012050611A2 Aptamers to glycoprotein vi
04/19/2012WO2012050402A2 Cell-permeable recombinant parkin protein and a pharmaceutical composition for treating degenerative brain diseases containing the same
04/19/2012WO2012050374A2 Immunotherapy for solid tumors
04/19/2012WO2012050353A2 Method whereby the base sequence of a target polynucleotide is non-specifically extended
04/19/2012WO2012050229A1 Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses
04/19/2012WO2012050198A1 Automated nucleic acid processor and automated nucleic acid processing method using multi function dispensing unit
04/19/2012WO2012050181A1 Prophylactic or therapeutic agent for fibrosis
04/19/2012WO2012050175A1 Method for producing glycoprotein having mannose residue as non-reducing end of sugar chain
04/19/2012WO2012050125A1 Method for producing monatin
04/19/2012WO2012049665A1 A modified human u1snrna molecule, a gene encoding for the modified human u1snrna molecule, an expression vector including the gene, and the use thereof in gene therapy
04/19/2012WO2012049663A1 Production of plants having improved water-deficit tolerance
04/19/2012WO2012049661A1 Production of plants with improved tolerance to water deficit
04/19/2012WO2012049658A1 Compound inhibiting tp53inp1 activity for the treatment of prostate cancer, and its use in screening and diagnostic methods
04/19/2012WO2012049654A1 Bacterial ribonucleic acid cell wall compositions and methods of making and using them
04/19/2012WO2012049431A2 Use of an anti-cd20 antibody for treating primary cerebral lymphoma
04/19/2012WO2012049366A1 Norovirus capsid and rotavirus vp6 protein for use as combined vaccine
04/19/2012WO2012049328A1 Generation of multifunctional and multivalent polypeptide complexes with collagen xviii trimerization domain
04/19/2012WO2012049314A1 Expression vector for cholesterol 24 -hydrolase in therapy of huntington' s disease
04/19/2012WO2012049306A1 Algal bio-flocculation by inactivation of photoreceptors
04/19/2012WO2012049268A1 Als inhibitor herbicide tolerant beta vulgaris mutants
04/19/2012WO2012049112A1 Egfr aptamer inhibitor for use in therapy and diagnosis
04/19/2012WO2012049108A1 Axl receptor tyrosine kinase aptamer inhibitor for use in therapy
04/19/2012WO2012048856A1 Proinsulin with helper sequence
04/19/2012WO2012048807A1 Methods for altering the reactivity of plant cell walls
04/19/2012WO2012048667A1 Epidermal growth factor receptor variant lacking exon
04/19/2012WO2012048653A1 Long-life interferon fusion protein and use thereof
04/19/2012WO2012048553A1 Escherichia coli tolc antigen, antibody and use thereof
04/19/2012WO2012048470A1 Small molecular ribonucleic acid complexes from mammals
04/19/2012WO2012048469A1 Deoxyribonucleic acid complex of small molecules from mammals
04/19/2012WO2012048430A1 Affinity-conjugated nucleoprotein-papaya mosaic virus-like particles and uses thereof
04/19/2012WO2012048385A1 Small viral rna molecules and uses thereof
04/19/2012WO2012015937A9 Parp1 targeted therapy
04/19/2012WO2012015270A3 Permissive cell line to the porcine reproductive and respiratory syndrome virus
04/19/2012WO2012009206A3 Sequencing reactions with alkali metal cations for pulse width control
04/19/2012WO2012007848A3 Meganuclease variants cleaving a dna target sequence in the was gene and uses thereof
04/19/2012WO2012006376A3 Virion-like delivery particles for self-replicating rna molecules
04/19/2012WO2012006329A3 Apoe4 and apoj biomarker-based prevention and treatment of dementia
04/19/2012WO2012006241A3 Methods and compositions for the specific inhibition of androgen receptor by double-stranded rna
04/19/2012WO2012000791A3 Diagnostic for localizing a diseased tissue
04/19/2012WO2011163557A3 Accumulation of omega-7 fatty acids in plant seeds
04/19/2012WO2011163312A3 Improving efficacy of cancer therapy
04/19/2012WO2011163249A3 Compositions, kits, and methods for synthesis and/or detection of nucleic acids
04/19/2012WO2011156520A3 Compositions and methods for increasing oil production and secretion
04/19/2012WO2011155973A3 Modified renilla luciferase nucleic acids and methods of use
04/19/2012WO2011155799A3 Mutant microorganism having a hydrocarbon-generating ability and method for producing hydrocarbon using same
04/19/2012WO2011153397A3 Treatment of inflammatory disorders
04/19/2012WO2011152694A3 Fusion protein having factor vii activity
04/19/2012WO2011150921A3 Biologically active molecules that are based on sirna and that can be activated in a cell-specific manner, method for activating same, and application kit for administration
04/19/2012WO2011150410A3 Tailored oils produced from recombinant heterotrophic microorganisms